Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV.
Laura LabateGiorgia BrucciGiulia CiccareseBianca BruzzoneValentina RicucciFederica StefanelliEmanuele DelfinoLucia TaramassoMatteo BassettiAntonio Di BiagioPublished in: International journal of STD & AIDS (2022)
Monkeypox (MPXV) usually causes a mild and self-limited infection. To date there are no data about cidofovir for the treatment for MPXV in humans. We report a case of a 25 years-old Brazilian man with a concurrent diagnosis of acute HIV (human immunodeficiency virus) infection, primary syphilis and MPXV infection with a nasal lesion successfully treated with intravenous cidofovir.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hiv positive
- men who have sex with men
- hiv testing
- newly diagnosed
- hiv infected
- hepatitis c virus
- hiv aids
- endothelial cells
- chronic rhinosinusitis
- high dose
- case report
- electronic health record
- squamous cell carcinoma
- low dose
- radiation therapy
- drug induced
- hepatitis b virus
- locally advanced
- acute respiratory distress syndrome
- replacement therapy